158 related articles for article (PubMed ID: 26267685)
21. Cardiovascular risk assessment and homocysteine and leptin levels in peritoneal dialysis and hemodialysis patients.
Bekpinar S; Unlüçerçi Y; Genç S; Türkmen A
Adv Perit Dial; 2005; 21():80-4. PubMed ID: 16686291
[TBL] [Abstract][Full Text] [Related]
22. Dialysis modality and nutritional status are associated with variability of inflammatory markers.
Snaedal S; Qureshi AR; Lund SH; Germanis G; Hylander B; Heimbürger O; Carrero JJ; Stenvinkel P; Bárány P
Nephrol Dial Transplant; 2016 Aug; 31(8):1320-7. PubMed ID: 27220753
[TBL] [Abstract][Full Text] [Related]
23. Correlation between volume overload, chronic inflammation, and left ventricular dysfunction in chronic kidney disease patients.
Hassan MO; Duarte R; Dix-Peek T; Vachiat A; Naidoo S; Dickens C; Grinter S; Manga P; Naicker S
Clin Nephrol; 2016 Supplement 1; 86 (2016)(13):131-135. PubMed ID: 27509588
[TBL] [Abstract][Full Text] [Related]
24. Growth hormone, IGF-I and its binding proteins (IGFBP-1 and -3) in adult uraemic patients undergoing peritoneal dialysis and haemodialysis.
Iglesias P; Díez JJ; Fernández-Reyes MJ; Méndez J; Bajo MA; Aguilera A; Selgas R
Clin Endocrinol (Oxf); 2004 Jun; 60(6):741-9. PubMed ID: 15163339
[TBL] [Abstract][Full Text] [Related]
25. Exploring binding characteristics and the related competition of different protein-bound uremic toxins.
Deltombe O; de Loor H; Glorieux G; Dhondt A; Van Biesen W; Meijers B; Eloot S
Biochimie; 2017 Aug; 139():20-26. PubMed ID: 28528271
[TBL] [Abstract][Full Text] [Related]
26. Longitudinal study of apoptosis in chronic uremic patients.
D'Intini V; Bordoni V; Fortunato A; Galloni E; Carta M; Galli F; Bolgan I; Inguaggiato P; Poulin S; Bonello M; Tetta C; Levin N; Ronco C
Semin Dial; 2003; 16(6):467-73. PubMed ID: 14629608
[TBL] [Abstract][Full Text] [Related]
27. Reduced Erythrocyte Survival in Uremic Patients Under Hemodialysis or Peritoneal Dialysis.
Bissinger R; Artunc F; Qadri SM; Lang F
Kidney Blood Press Res; 2016; 41(6):966-977. PubMed ID: 27941327
[TBL] [Abstract][Full Text] [Related]
28. Uremic serum inhibits in vitro expression of chemokine SDF-1: impact of uremic toxicity on endothelial injury.
Ribeiro V; Bosquetti B; Gonçalves SM; Bucharles SG; Rempel L; Maciel RA; de Oliveira RB; Pecoits-Filho R; Stinghen AE
J Bras Nefrol; 2014; 36(2):123-31. PubMed ID: 25055351
[TBL] [Abstract][Full Text] [Related]
29. Interleukin-2 serum levels are elevated in patients with uremic pruritus: a novel finding with practical implications.
Fallahzadeh MK; Roozbeh J; Geramizadeh B; Namazi MR
Nephrol Dial Transplant; 2011 Oct; 26(10):3338-44. PubMed ID: 21372257
[TBL] [Abstract][Full Text] [Related]
30. Genetic damage in patients with chronic kidney disease, peritoneal dialysis and haemodialysis: a comparative study.
Rangel-López A; Paniagua-Medina ME; Urbán-Reyes M; Cortes-Arredondo M; Alvarez-Aguilar C; López-Meza J; Ochoa-Zarzosa A; Lindholm B; García-López E; Paniagua JR
Mutagenesis; 2013 Mar; 28(2):219-25. PubMed ID: 23408844
[TBL] [Abstract][Full Text] [Related]
31. Exploring Protein Binding of Uremic Toxins in Patients with Different Stages of Chronic Kidney Disease and during Hemodialysis.
Deltombe O; Van Biesen W; Glorieux G; Massy Z; Dhondt A; Eloot S
Toxins (Basel); 2015 Sep; 7(10):3933-46. PubMed ID: 26426048
[TBL] [Abstract][Full Text] [Related]
32. Neutrophil to lymphocyte ratio in evaluation of inflammation in patients with chronic kidney disease.
Okyay GU; Inal S; Oneç K; Er RE; Paşaoğlu O; Paşaoğlu H; Derici U; Erten Y
Ren Fail; 2013; 35(1):29-36. PubMed ID: 23113674
[TBL] [Abstract][Full Text] [Related]
33. Effects of chronic kidney disease and type of dialysis on serum levels of adiponectin, TNF-alpha and high sensitive C-reactive protein.
Kir HM; Eraldemir C; Dervisoglu E; Caglayan C; Kalender B
Clin Lab; 2012; 58(5-6):495-500. PubMed ID: 22783580
[TBL] [Abstract][Full Text] [Related]
34. Lipid abnormalities and oxidized LDL in chronic kidney disease patients on hemodialysis and peritoneal dialysis.
Samouilidou EC; Karpouza AP; Kostopoulos V; Bakirtzi T; Pantelias K; Petras D; Tzanatou-Exarchou H; J Grapsa E
Ren Fail; 2012; 34(2):160-4. PubMed ID: 22172020
[TBL] [Abstract][Full Text] [Related]
35. A high calcium-phosphate product is associated with high C-reactive protein concentrations in hemodialysis patients.
Movilli E; Feliciani A; Camerini C; Brunori G; Zubani R; Scolari F; Parrinello G; Cancarini GC
Nephron Clin Pract; 2005; 101(4):c161-7. PubMed ID: 16103720
[TBL] [Abstract][Full Text] [Related]
36. Role of platelet surface receptor abnormalities in the bleeding and thrombotic diathesis of uremic patients on hemodialysis and peritoneal dialysis.
Salvati F; Liani M
Int J Artif Organs; 2001 Mar; 24(3):131-5. PubMed ID: 11314805
[TBL] [Abstract][Full Text] [Related]
37. Hyperleptinemia in uremic patients undergoing conservative management, peritoneal dialysis, and hemodialysis: A comparative analysis.
Fontán MP; Rodríguez-Carmona A; Cordido F; García-Buela J
Am J Kidney Dis; 1999 Nov; 34(5):824-31. PubMed ID: 10561137
[TBL] [Abstract][Full Text] [Related]
38. Serum and erythrocyte tocopherol in uremic patients: effect of hemodialysis versus peritoneal dialysis.
Pastor MC; Sierra C; Bonal J; Teixidó J
Am J Nephrol; 1993; 13(4):238-43. PubMed ID: 8267019
[TBL] [Abstract][Full Text] [Related]
39. A Comparative Study of C-Reactive Protein Plasma Levels in Patients on Hemodialysis and Peritoneal Dialysis.
Fernández-Reyes MJ; Hevia C; Bajo MA; Peso GD; Costero O; Diez JJ; Selgas R
Hemodial Int; 2001 Jan; 5(1):55-58. PubMed ID: 28452446
[TBL] [Abstract][Full Text] [Related]
40. Correlation of increased Th17/Treg cell ratio with endoplasmic reticulum stress in chronic kidney disease.
Zhu X; Li S; Zhang Q; Zhu D; Xu Y; Zhang P; Han J; Duan Z; Gao J; Ou Y
Medicine (Baltimore); 2018 May; 97(20):e10748. PubMed ID: 29768353
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
